Physician
California Managed Imaging Medical Group, INC
California Managed Imaging Medical Group, INC was paid $19.32M by Medicaid between Jan 2018 and Nov 2024, across 106 billing codes. Its largest line is 74177, Computed tomography, abdomen and pelvis; with contrast material — 17% of everything it billed.
33Billing provider infoCALIFORNIA MANAGED IMAGING MEDICAL GROUP, INC
SANTA BARBARA, CA 93105
SANTA BARBARA, CA 93105
33aNPI1821271727assigned 12/13/2007
33bProvider typeVascular & Interventional Radiology Physician
28Total paid$19.32M
24GClaims607,941
24DCodes billed106
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Vascular & Interventional Radiology Physician providers in California
Rank by total paid#2 of 81
Median peer was paid$6K
This provider vs. median3,247×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 40,472 | $443K | |
| 2019 | 67,553 | $1.77M | |
| 2020 | 68,165 | $2.08M | |
| 2021 | 107,330 | $3.48M | |
| 2022 | 128,244 | $4.15M | |
| 2023 | 124,659 | $4.56M | |
| 2024incomplete | 71,518 | $2.84M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 17% | 39,037 | 38,122 | $3.27M |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 15% | 34,156 | 33,082 | $2.87M |
| 70450 | Computed tomography, head or brain; without contrast material | 8.9% | 51,387 | 49,016 | $1.71M |
| 71045 | Radiologic examination, chest; single view | 8.0% | 214,109 | 191,059 | $1.54M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 6.8% | 17,906 | 17,336 | $1.31M |
| 77063 | Screening digital breast tomosynthesis, bilateral | 6.4% | 33,577 | 32,522 | $1.24M |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 4.0% | 25,854 | 25,170 | $781K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 4.0% | 11,783 | 11,634 | $767K |
| 71046 | Radiologic examination, chest; 2 views | 3.3% | 56,149 | 55,143 | $637K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 3.0% | 3,129 | 2,970 | $580K |
| 76830 | Ultrasound, transvaginal | 3.0% | 6,946 | 6,847 | $577K |
| 76642 | 2.1% | 5,233 | 4,987 | $403K |
94 more codes
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 1.9% | 5,288 | $364K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 1.7% | 2,414 | $335K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 1.2% | 2,397 | $232K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1.1% | 3,201 | $222K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 4,248 | $171K |
| 73221 | <1% | 828 | $142K | |
| 76770 | <1% | 3,205 | $136K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 2,719 | $116K |
| 76641 | <1% | 699 | $115K | |
| 76801 | <1% | 2,548 | $113K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 217 | $105K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 696 | $104K |
| 93976 | <1% | 2,332 | $100K | |
| 71250 | <1% | 2,114 | $89K | |
| 73630 | <1% | 7,383 | $85K | |
| 74018 | <1% | 8,231 | $79K | |
| 70496 | <1% | 999 | $72K | |
| 73030 | <1% | 5,500 | $71K | |
| 70498 | <1% | 1,005 | $69K | |
| 93970 | <1% | 1,788 | $66K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 1,185 | $65K |
| 72100 | <1% | 3,136 | $60K | |
| 76377 | <1% | 2,056 | $57K | |
| 73610 | <1% | 5,078 | $53K | |
| 77066 | Tomosynthesis, mammo | <1% | 409 | $51K |
| 74178 | <1% | 217 | $49K | |
| 93971 | <1% | 2,241 | $46K | |
| 73562 | <1% | 2,627 | $45K | |
| 73564 | <1% | 2,974 | $37K | |
| 72141 | <1% | 305 | $31K | |
| 77065 | Tomosynthesis, mammo | <1% | 387 | $30K |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 792 | $27K |
| 73502 | <1% | 2,086 | $26K | |
| 76536 | <1% | 255 | $23K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 792 | $23K |
| 73130 | <1% | 2,217 | $22K | |
| 77080 | <1% | 2,094 | $20K | |
| 49083 | <1% | 160 | $20K | |
| 74174 | <1% | 209 | $20K | |
| 71271 | <1% | 276 | $17K | |
| 73110 | <1% | 1,310 | $12K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,304 | $10K |
| 70486 | <1% | 265 | $10K | |
| 99053 | <1% | 5,137 | $9K | |
| 76870 | <1% | 112 | $7K | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 562 | $7K |
| 99152 | <1% | 400 | $6K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 215 | $6K |
| 77062 | <1% | 80 | $5K | |
| 72131 | <1% | 190 | $5K | |
| 73560 | <1% | 771 | $5K | |
| 93975 | <1% | 58 | $5K | |
| 72110 | <1% | 181 | $4K | |
| 72040 | <1% | 173 | $4K | |
| 74230 | <1% | 187 | $4K | |
| 73590 | <1% | 538 | $3K | |
| 76376 | <1% | 183 | $3K | |
| 73700 | <1% | 68 | $3K | |
| 73140 | <1% | 359 | $2K | |
| 73552 | <1% | 213 | $2K | |
| 73080 | <1% | 219 | $2K | |
| 76937 | <1% | 325 | $1K | |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | <1% | 37 | $1K |
| 71101 | <1% | 86 | $878.97 | |
| 73090 | <1% | 169 | $857.53 | |
| 77061 | <1% | 13 | $725.37 | |
| 72128 | <1% | 30 | $698.52 | |
| 77001 | <1% | 186 | $668.60 | |
| 78226 | <1% | 25 | $598.64 | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 17 | $595.13 |
| 77014 | <1% | 14 | $539.44 | |
| 78582 | <1% | 12 | $515.76 | |
| 72170 | <1% | 67 | $413.32 | |
| 78264 | <1% | 12 | $386.47 | |
| 72020 | <1% | 50 | $319.45 | |
| 71020 | <1% | 35 | $281.05 | |
| 73600 | <1% | 32 | $278.19 | |
| 73060 | <1% | 57 | $275.79 | |
| 36569 | <1% | 66 | $238.51 | |
| 74019 | <1% | 35 | $172.60 | |
| 74022 | <1% | 12 | $155.25 | |
| 73100 | <1% | 13 | $124.79 | |
| 73521 | <1% | 15 | $121.45 | |
| 71010 | <1% | 14 | $85.34 | |
| 73660 | <1% | 13 | $48.86 | |
| G9637 | Final reports with documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique) | 0% | 4,274 | $0.00 |
| G9557 | Final reports for ct, cta, mri or mra studies of the chest or neck without an incidentally found thyroid nodule < 1.0 cm noted or no nodule found | 0% | 715 | $0.00 |
| G9756 | Surgical procedures that included the use of silicone oil | 0% | 83 | $0.00 |
| 7025F | 0% | 148 | $0.00 | |
| G9550 | Final reports for imaging studies with follow-up imaging recommended, or final reports that do not include a specific recommendation of no follow-up | 0% | 31 | $0.00 |
| 3341F | 0% | 63 | $0.00 | |
| G9547 | Cystic renal lesion that is simple appearing (bosniak i or ii) , or adrenal lesion less than or equal to 1.0 cm or adrenal lesion greater than 1.0 cm but less than or equal to 4.0 cm classified as likely benign by unenhanced ct or washout protocol ct, or mri with in- and opposed-phase sequences or other equivalent institutional imaging protocols | 0% | 31 | $0.00 |
| G9551 | Final reports for imaging studies without an incidentally found lesion noted | 0% | 1,852 | $0.00 |
| G9500 | Radiation exposure indices documented in final report for procedure using fluoroscopy | 0% | 310 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTRAUBE, LAURA (PRESIDENT)